Exploring the Multifaceted Therapeutic Potential of Delta-8-THC from Hemp
Emerging preclinical studies, clinical research, and user experiences shed light on the diverse therapeutic benefits of Delta-8-THC, a remarkable cannabinoid found in Hemp. As a minor cannabinoid, it's important to approach its use with caution due to the ongoing research.
Anti-Inflammatory and Pain-Relieving Properties:
A 2018 study in 'Cannabis and Cannabinoid Research' highlighted Delta-8-THC's potential in reducing pain and inflammation, particularly in a corneal injury in mice. The compound, when applied topically, showed significant pain relief and anti-inflammatory effects via the CB1 receptors. Another study on rats also noted its pain-relieving properties, though tolerance developed quickly.
Anxiety Relief Insights: The U.S. National Library of Medicine notes Delta-8-THC's anxiolytic effects, akin to Delta-9-THC. While comprehensive clinical studies are sparse, anecdotal evidence suggests that Delta-8-THC offers a calming, focused experience, potentially without the anxiety commonly associated with Delta-9-THC.
Combatting Nausea: A notable 1995 study in 'Life Sciences' revealed Delta-8-THC's efficacy in combating nausea. Observing pediatric cancer patients, the study found significant nausea reduction with minimal side effects when Delta-8-THC was administered around cancer treatments.
Appetite Stimulation: A 2004 'Pharmacology, Biochemistry and Behavior' study on mice demonstrated that Delta-8-THC could significantly stimulate appetite, even more than Delta-9-THC, a known appetite enhancer. A small dose led to a 22% increase in food intake over a 50-day period.
As research continues to unfold, the potential of Delta-8-THC in therapeutic applications becomes increasingly evident, offering a promising avenue for Hemp-derived cannabinoid treatments.